Schrijvers D - Search Results

1

Role of red blood cells in pharmacokinetics of chemotherapeutic agents.

Schrijvers D, Highley M, De Bruyn E, Van Oosterom AT, Vermorken JB. Schrijvers D, et al. Anticancer Drugs. 1999 Feb;10(2):147-53. doi: 10.1097/00001813-199902000-00002. Anticancer Drugs. 1999. PMID: 10211544 Review.

2

KW-2149-induced pulmonary toxicity is not prevented by corticosteroids: a phase I and pharmacokinetic study.

Schrijvers D, Catimel G, Highley M, Höppener FJ, Dirix L, De Bruijn E, Droz JP, Van Oosterom AT. Schrijvers D, et al. Anticancer Drugs. 1999 Aug;10(7):633-9. doi: 10.1097/00001813-199908000-00002. Anticancer Drugs. 1999. PMID: 10507312 Clinical Trial.

3

Docetaxel (Taxotere), a review of preclinical and clinical experience. Part II: Clinical experience.

van Oosterom AT, Schrijvers D, Schriivers D [corrected to Schrijvers D]. van Oosterom AT, et al. Among authors: schrijvers d. Anticancer Drugs. 1995 Jun;6(3):356-68. doi: 10.1097/00001813-199506000-00002. Anticancer Drugs. 1995. PMID: 7670133 Review.

4

Activated oxazaphosphorines are transported predominantly by erythrocytes.

Highley MS, Schrijvers D, Van Oosterom AT, Harper PG, Momerency G, Van Cauwenberghe K, Maes RA, De Bruijn EA, Edelstein MB. Highley MS, et al. Among authors: schrijvers d. Ann Oncol. 1997 Nov;8(11):1139-44. doi: 10.1023/a:1008261203803. Ann Oncol. 1997. PMID: 9426334 Free article.

5

Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature.

Pelgrims J, De Vos F, Van den Brande J, Schrijvers D, Prové A, Vermorken JB. Pelgrims J, et al. Among authors: schrijvers d. Br J Cancer. 2000 Jan;82(2):291-4. doi: 10.1054/bjoc.1999.0917. Br J Cancer. 2000. PMID: 10646879 Free PMC article. Review.

6

Role of taxoids in head and neck cancer.

Schrijvers D, Vermorken JB. Schrijvers D, et al. Oncologist. 2000;5(3):199-208. doi: 10.1634/theoncologist.5-3-199. Oncologist. 2000. PMID: 10884498 Free article. Review.

7

Pharmacokinetics of ifosfamide are changed by combination with docetaxel: results of a phase I pharmacologic study.

Schrijvers D, Pronk L, Highley M, Bruno R, Locci-Tonelli D, De Bruijn E, Van Oosterom AT, Verweij J. Schrijvers D, et al. Am J Clin Oncol. 2000 Aug;23(4):358-63. doi: 10.1097/00000421-200008000-00010. Am J Clin Oncol. 2000. PMID: 10955864 Clinical Trial.

8

Phase I study of MEN-10755, a new anthracycline in patients with solid tumours: a report from the European Organization for Research and Treatment of Cancer, Early Clinical Studies Group.

Schrijvers D, Bos AM, Dyck J, de Vries EG, Wanders J, Roelvink M, Fumoleau P, Bortini S, Vermorken JB. Schrijvers D, et al. Ann Oncol. 2002 Mar;13(3):385-91. doi: 10.1093/annonc/mdf061. Ann Oncol. 2002. PMID: 11996468 Free article. Clinical Trial.

9

A phase I study of bendamustine hydrochloride administered day 1+2 every 3 weeks in patients with solid tumours.

Rasschaert M, Schrijvers D, Van den Brande J, Dyck J, Bosmans J, Merkle K, Vermorken JB. Rasschaert M, et al. Among authors: schrijvers d. Br J Cancer. 2007 Jun 4;96(11):1692-8. doi: 10.1038/sj.bjc.6603776. Epub 2007 May 8. Br J Cancer. 2007. PMID: 17486132 Free PMC article. Clinical Trial.

10

Recent developments in the biology and management of advanced bladder cancer.

van Oosterom AT, Schrijvers D. van Oosterom AT, et al. Among authors: schrijvers d. Eur J Cancer. 1995;31A(5):838-9. doi: 10.1016/0959-8049(95)00111-u. Eur J Cancer. 1995. PMID: 7640075 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

281 results

Search Page